Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Amylin rejects Bristol-Myers Squibb’s 3.5 billion purchase offer.
Amylin rejects Bristol-Myers Squibb’s 3.5 billion purchase offer.
Mar 28, 20121,533 views
Home / KEEP BUT DO NOT DISPLAY / Alerts / Amylin rejects Bristol-Myers Squibb’s 3.5 billion purchase offer.
|
|
|
|